Literature DB >> 8894609

Neuronal responses to delta 9-tetrahydrocannabinol in the solitary tract nucleus.

T Himmi1, M Dallaporta, J Perrin, J C Orsini.   

Abstract

The effects of delta 9-tetrahydrocannabinol on single-unit activity in the subpostremal division of the nucleus tractus solitarii were investigated by extracellular recording in rat brain slices. The spontaneous firing rate of 54.8% of the recorded neurons was significantly changed after bath applications of delta 9-tetrahydrocannabinol. Putative nutrition-related neurons responding to a moderate increase in glucose concentration were selectively sensitive to delta 9-tetrahydrocannabinol. The delta 9-tetrahydrocannabinol-sensitive neurons were depressed by clonidine and are therefore likely to be adrenergic or noradrenergic. These observations suggest that some catecholaminergic, glucose-responsive neurons in the subpostremal nucleus tractus solitarii might mediate the influence of cannabinoids on feeding behaviour. Furthermore, most delta 9-tetrahydrocannabinol-sensitive neurons in the nucleus tractus solitarii showed opposite responses to delta 9-tetrahydrocannabinol and the 5-HT3 receptor agonist 1-phenylbiguanide, and might therefore be involved in the nausea-reducing effects of cannabinoids.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8894609     DOI: 10.1016/0014-2999(96)00490-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

Review 1.  Cannabinoid modulation of noradrenergic circuits: implications for psychiatric disorders.

Authors:  Ana Franky Carvalho; Elisabeth J Van Bockstaele
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-01-24       Impact factor: 5.067

Review 2.  Regulation of nausea and vomiting by cannabinoids.

Authors:  Linda A Parker; Erin M Rock; Cheryl L Limebeer
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

3.  Association of Marijuana Use With Psychosocial and Quality of Life Outcomes Among Patients With Head and Neck Cancer.

Authors:  Han Zhang; Michael Xie; Stuart D Archibald; B Stanley Jackson; Michael K Gupta
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-11-01       Impact factor: 6.223

4.  Cannabinoids suppress synaptic input to neurones of the rat dorsal motor nucleus of the vagus nerve.

Authors:  Andrei V Derbenev; Thomas C Stuart; Bret N Smith
Journal:  J Physiol       Date:  2004-07-22       Impact factor: 5.182

5.  A comparative analysis of the potential of cannabinoids and ondansetron to suppress cisplatin-induced emesis in the Suncus murinus (house musk shrew).

Authors:  Magdalena Kwiatkowska; Linda A Parker; Page Burton; Raphael Mechoulam
Journal:  Psychopharmacology (Berl)       Date:  2004-07       Impact factor: 4.530

Review 6.  [Review of cannabinoids in the treatment of nausea and vomiting].

Authors:  L Radbruch; F Nauck
Journal:  Schmerz       Date:  2004-08       Impact factor: 1.107

7.  Astrocytes in the nucleus of the solitary tract are activated by low glucose or glucoprivation: evidence for glial involvement in glucose homeostasis.

Authors:  David H McDougal; Gerlinda E Hermann; Richard C Rogers
Journal:  Front Neurosci       Date:  2013-12-20       Impact factor: 4.677

8.  Cannabinoid receptor activation in the nucleus tractus solitaries produces baroreflex-like responses in the rat.

Authors:  Murat S Durakoglugil; Hakan S Orer
Journal:  Int J Biomed Sci       Date:  2008-09

Review 9.  The Endocannabinoid System as Pharmacological Target Derived from Its CNS Role in Energy Homeostasis and Reward. Applications in Eating Disorders and Addiction.

Authors:  Maria-Paz Viveros; Francisco-Javier Bermúdez-Silva; Ana-Belén Lopez-Rodriguez; Edward J Wagner
Journal:  Pharmaceuticals (Basel)       Date:  2011-08-10

Review 10.  Glial Modulation of Energy Balance: The Dorsal Vagal Complex Is No Exception.

Authors:  Jean-Denis Troadec; Stéphanie Gaigé; Manon Barbot; Bruno Lebrun; Rym Barbouche; Anne Abysique
Journal:  Int J Mol Sci       Date:  2022-01-16       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.